Technology News and Research

RSS

Adequate building ventilation can help tackle airborne transmission of Covid-19

Adequate building ventilation can help tackle airborne transmission of Covid-19

Preventing airborne transmission of Covid-19 should be the next front of the battle against the virus, argue experts from the University of Surrey.

28 May 2020

Some ivory towers are ideal for a pandemic. Most aren’t.

Some ivory towers are ideal for a pandemic. Most aren’t.

Saint Mary's College in Moraga, California, is open for business this fall — but to get there, you really have to want it. Tucked amid verdant hills 23 miles east of San Francisco, accessible by a single road and a single entrance, the small, private Roman Catholic school receives almost no visitors by accident.

28 May 2020

PKU-led team identifies potent neutralizing antibodies against SARS-CoV-2

PKU-led team identifies potent neutralizing antibodies against SARS-CoV-2

A joint research team led by Sunney Xie, Director of Beijing Advanced Innovation Center for Genomics at Peking University has successfully identified multiple highly potent neutralizing antibodies against the novel coronavirus SARS-CoV-2, the causative virus of the respiratory disease COVID-19, from convalescent plasma by high-throughput single-cell sequencing.

28 May 2020

Antibody tests were hailed as way to end lockdowns. Instead, they cause confusion.

Antibody tests were hailed as way to end lockdowns. Instead, they cause confusion.

Aspen was an early COVID-19 hot spot in Colorado, with a cluster of cases in March linked to tourists visiting for its world-famous skiing. Tests were in short supply, making it difficult to know how the virus was spreading.

28 May 2020

Shandong University offers high-tech support to fight against coronavirus epidemic

Shandong University offers high-tech support to fight against coronavirus epidemic

Since the COVID-19 outbreak, the SDU-NTU Joint Centre for Artificial Intelligence Research has developed two types of robots, which were sent to hospitals in Wuhan and Huanggang in China’s Hubei Province to aid front-line fight against the coronavirus epidemic.

28 May 2020

Digital platform can help reduce healthcare-related infections in surgical environments

Digital platform can help reduce healthcare-related infections in surgical environments

One in ten people in hospital care develops a healthcare-related infection. Together with Getinge, Semcon is developing a new digital platform to make it easier to identify where the risk of infections during surgery is greatest.

28 May 2020

Thermo Fisher Scientific and Biognosys extend partnership to advance DIA mass spectrometry-based workflows

Thermo Fisher Scientific and Biognosys extend partnership to advance DIA mass spectrometry-based workflows

Thermo Fisher Scientific, the world leader in serving science, and Biognosys, a leading developer of next-generation proteomics solutions, announce they are continuing their collaboration to advance data independent acquisition mass spectrometry-based workflows.

From Thermo Fisher Scientific Inc. 28 May 2020

Thermo Fisher Scientific announces license agreement to develop, commercialize deep learning tools for proteomics

Thermo Fisher Scientific announces license agreement to develop, commercialize deep learning tools for proteomics

Thermo Fisher Scientific, the world leader in serving science, and MSAID GmbH, a software company transforming proteomics with deep learning, announce an exclusive license agreement to develop and commercialize deep learning tools for proteomics, making MSAID’s Prosit-derived framework widely accessible to proteomics laboratories.

From Thermo Fisher Scientific Inc. 28 May 2020

New Thermo Scientific Proteome Discoverer 2.5 software strengthens laboratory workflows

New Thermo Scientific Proteome Discoverer 2.5 software strengthens laboratory workflows

Scientists in the life sciences can now benefit from upgrades to a suite of analytical software solutions with new features designed to enhance productivity, confidence and accuracy in numerous fields, including proteomics, food safety and biotherapeutic drug development.

From Thermo Fisher Scientific Inc. 28 May 2020

New high-resolution mass spectrometer expands the proven Thermo Scientific Orbitrap platform

New high-resolution mass spectrometer expands the proven Thermo Scientific Orbitrap platform

A new generation, high resolution mass spectrometer (MS) is designed to give proteomics, metabolomics, biopharmaceutical characterization and small-molecule scientists the analytical performance required for research and high-throughput analyses.

From Thermo Fisher Scientific Inc. 28 May 2020

New Orbitrap Exploris 120 mass spectrometer redefines productivity in small molecule applications

New Orbitrap Exploris 120 mass spectrometer redefines productivity in small molecule applications

Scientists working across small molecule applications require systems that support extensive, in-depth analysis of multiple complex samples, while simultaneously increasing output and decreasing costs.

From Thermo Fisher Scientific Inc. 28 May 2020

AXT offer Fluicell’s innovative range of tissue engineering systems in Australia & NZ

AXT offer Fluicell’s innovative range of tissue engineering systems in Australia & NZ

AXT are proud to announce that they have just expanded their life science product portfolio with the addition of Fluicell’s innovative tissue engineering systems. The new agreement will see AXT exclusively distribute their Biopixlar and BioPen product lines in Australia and New Zealand.

From AXT Pty Ltd 28 May 2020

Measuring the binding of SARS-CoV-2 antibodies to the COVID spike protein using SPR

Measuring the binding of SARS-CoV-2 antibodies to the COVID spike protein using SPR

Ryan Denomme, the CEO of Nicoya, speaks to News-Medical on their SARS-CoV-2 research using their SPR technology.

From Nicoya Lifesciences 28 May 2020

Excelitas Technologies’ Qioptiq Subsidiary Builds New Göttingen Plant

Excelitas Technologies’ Qioptiq Subsidiary Builds New Göttingen Plant

Excelitas Technologies® Corp. announces that its Qioptiq® subsidiary begins the construction for a new factory in Göttingen, Germany.

From Excelitas Technologies 28 May 2020

Clinical trial of COVID-19 vaccine starts in Australia

Clinical trial of COVID-19 vaccine starts in Australia

Over 100 candidate vaccines are being explored as a means of ending the COVID-19 pandemic. Eight of these have already made it to clinical trials in humans, and another 94 are in the pre-clinical evaluation stage.

27 May 2020

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

UTSW/Children's Health joint program approved as Certified Duchenne Care Center

A joint program of UT Southwestern Medical Center and Children's Health has been approved as a Certified Duchenne Care Center by Parent Project Muscular Dystrophy, the nation's most comprehensive nonprofit organization focused on finding a cure for Duchenne muscular dystrophy.

27 May 2020

WVU partnership produces thousands of swabs to meet demands for COVID-19 testing

WVU partnership produces thousands of swabs to meet demands for COVID-19 testing

With significantly increased testing a key component in the battle against COVID-19, the Innovation Hub at West Virginia University is working with WVU Medicine to churn out up to 10,000 swabs weekly to meet demands for tests.

27 May 2020

City experts to develop a hybrid sensor for detection of diabetes

City experts to develop a hybrid sensor for detection of diabetes

Dr Sumsun Naher and Professor Aziz Rahman have received a Marie Curie Fellowship to develop a hybrid sensor for the detection of diabetes from exhaled breath.

27 May 2020

Simple urine-testing method for people with kidney stones offers results in 30 minutes

Simple urine-testing method for people with kidney stones offers results in 30 minutes

An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.

27 May 2020

Masks can help reduce asymptomatic spread of SARS-CoV-2 in aerosols

Masks can help reduce asymptomatic spread of SARS-CoV-2 in aerosols

Growing evidence suggests that SARS-CoV-2, the novel coronavirus that causes COVID-19, can be spread by asymptomatic people via aerosols -- a reality that deeply underscores the ongoing importance of regular widespread testing, wearing masks and physical distancing to reduce the spread of the virus, say Kimberly Prather and colleagues in a new Perspective.

27 May 2020

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.